AN2 Therapeutics, Inc.
$5.58
-0.16 (-2.79%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +4.7%
- 3 Months
- +28.9%
- YTD
- +389.5%
- 1 Year
- +389.5%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 131.6%
- Largest decline max drawdown, since Aug 2025
- -45.6%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.71
Own ANTX?
See how ANTX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.